Company Profile

  1. You are here:    Home
  2. Search Databases
  3. Search Company Registry
  4. Company Profile

Academic Pharmaceuticals Inc
Profile last edited on: 11/20/19      CAGE: 4BPH3      UEI: ZC8ZATDAATL9

Business Identifier: Cardiovascular products
Year Founded
1992
First Award
2005
Latest Award
2019
Program Status
Inactive
Popularity Index

Edit Company Profile

Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.
  Explanation Edit

Location Information

21 Skokie Valley Road Suite G3
Lake Bluff, IL 60044
   (847) 735-1170
   N/A
   N/A
Location: Single
Congr. District: 10
County: Lake

Public Profile

Specializing in cardiovascular products, Academic Pharmaceuticals Inc is an R&D firm developing anti-arrhythmic parenteral compounds and other cardiovascular drugs needed by practicing cardiologists or emergency room physicians. Many of the products in development are orphan drugs that serve specialized populations. The company's expertise is in solubilization of insoluble compounds and designing expedited clinical development and regulatory review programs.

Extent of SBIR involvement

User Avatar
Phase I Awards
6
Phase II Awards
0
Conversion Rate
0.00%
Phase I Dollars
$766,806
Phase II Dollars
$0
Total Awarded
$766,806

Synopsis: Awardee Business Condition

Employee Range
1-4
Revenue Range
Less than .5M
VC funded?
No
Public/Private
Privately Held
Stock Info
----
IP Holdings
5-9

Awards Distribution by Agency

Most Recent SBIR Projects
Year Phase Agency Total Amount
2019 1 NIH $158,460
Project Title: Developing a Parenteral Formulation of Metolazone
2019 1 NIH $153,260
Project Title: Soestolol: a Potentially Short Acting Type III Anti-Arrhythmic
2017 1 NIH $149,980
Project Title: A Safer Cardiac, Abuse Deterrent Formulation of Methadone
2010 1 NIH $102,910
Project Title: Reducing Methadone's Arrhythmic Potential
2009 1 NIH $100,188
Project Title: Pediatric Acceptable Formulation Of Amiodarone

Key People / Management

  John C Somberg -- President

  Janos Molnar -- Director of Clinical Research

Company News

There are no news available.